3,0
21. Juni 2016
Mitarbeiter (anonym)
Aktueller Mitarbeiter
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
The organization strives to make a real impact on how clinical trials are conducted with a participant and site focus ensuring that trial data is delivered cleaner and quicker than traditional EDC which increases participant safety.
Kontras
Directionally, the organization is somewhat shifting from its original focus (as noted in Pros) and is losing some of what makes it unique.